Asteria Health Recalls Testosterone Sterile Pellets Due to Potential Metal Particulate Matter
Areazine synthesizes this FDA recall directly from FDA's official public data feed. See our methodology for full source attribution and refresh cadence.
F.H. INVESTMENTS, Inc. (dba Asteria Health) is recalling 153,498 testosterone pellets nationwide due to the potential presence of metal particulate matter in the sterile product.
What this FDA recall tells you, and what most readers miss
This notice was issued by FDA on April 6, 2026 and geographically references United States. Its severity classification of "high" signals how the issuing agency weighs the risk of harm if no action is taken - "critical" and "high" tier alerts typically carry direct consumer actions, while "medium" and "low" tend toward informational guidance or monitoring advisories. The category it belongs to - FDA Recalls - determines the consumer-protection framework behind it, which shapes what remedies (refunds, replacements, repairs, or the recall itself) are available to affected consumers and which agency holds statutory responsibility for enforcement.
Most readers skim a notice like this, check whether they are personally affected, and move on. The more useful lens is to verify its scope, source, and timestamp, then compare related notices without assuming that one record proves a broader trend.
Areazine pairs this record with the original agency URL so you can check the primary source before acting. Its related labels are recall, product-safety, fda, drugs.
What Happened
F.H. INVESTMENTS, Inc., doing business as Asteria Health, has initiated a voluntary recall of several lots of its Testosterone sterile pellets. The recall was prompted by the discovery of a foreign substance, specifically the potential presence of metal particulate matter, within the product. The FDA has classified this as a Class II recall.
Which Products Are Affected
The recall affects 153,498 units of the following product distributed nationwide across the United States:
- Product Name: Testosterone, 100 mg, 1 Sterile Pellet
- NDC Number: 79559-1100-32
- Manufacturer: Asteria Health, 432 Industrial Ln, Birmingham, AL 35211
- Affected Lot Numbers and Expiration Dates:
- Lot 251000132 (Exp. 06/16/2026)
- Lot 251000142 (Exp. 06/30/2026)
- Lot 251000144 (Exp. 07/14/2026)
- Lot 251000146 (Exp. 07/21/2026)
- Lot 251000162 (Exp. 08/16/2026)
- Lot 251000163 (Exp. 08/16/2026)
- Lot 251000167 (Exp. 08/22/2026)
- Lot 251000177 (Exp. 09/12/2026)
What You Should Do
Healthcare providers and consumers who have the affected lots should immediately stop using the product. Asteria Health notified its customers of the recall via letter starting on January 26, 2026. For further information regarding returns or specific instructions, parties should contact F.H. INVESTMENTS, Inc. at their Birmingham, Alabama location.
Why This Matters
The presence of metal particulate matter in a sterile drug product intended for implantation poses a serious health risk, as it can lead to inflammation, irritation, or other adverse tissue reactions at the site of administration.
Source
This information is based on official recall data from the FDA under recall number D-0323-2026.
Original source: FDA Official Notice ↗
Related FDA Recalls
All FDA Recalls →Frequently Asked Questions
Common questions about this FDA recall.